Doctor profile · Federal record
Dr. Uchenna Nebeolisa, NP
Family Nurse Practitioner (CMS: Nurse Practitioner) · Dallas, TX
- NPI 1992207872
- Accepts Medicare
- 9 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
655 W Illinois Ave Ste 916
Dallas, TX 752241814
(214) 941-7611 - Mailing address
-
122 W John Carpenter Fwy Ste 420
Irving, TX 750392014
Credentials & registration
- NPI registered
- March 2018 — 8 yrs on file
- Profile last updated
- April 25, 2018
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Texas #AP136397
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1992207872. Last verified May 11, 2026.Open Payments
Industry payments received
All-time total
$61
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Ucb, INC. | 1 | $36.58 | |
| Phadia US INC. | 1 | $24.18 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
71
Patients
39
Total drug cost
$960
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 27 | 24 | $356 |
| Amlodipine Besylate | Generic | 19 | 15 | $245 |
| Lisinopril-Hydrochlorothiazide (Lisinopril/Hydrochlorothiazide) | Brand | 14 | 0 | $147 |
| Omeprazole | Generic | 11 | 0 | $212 |
Frequently asked questions
What is Dr. Uchenna Nebeolisa's medical specialty?
Dr. Uchenna Nebeolisa practices Family Nurse Practitioner in Dallas, TX.
Where does Dr. Uchenna Nebeolisa practice?
Dr. Uchenna Nebeolisa practices at 655 W Illinois Ave Ste 916, Dallas, TX 752241814. Office phone: 2149417611.
What is Dr. Uchenna Nebeolisa's NPI?
Dr. Uchenna Nebeolisa's National Provider Identifier (NPI) is 1992207872, issued by NPPES.
Does Dr. Uchenna Nebeolisa accept Medicare assignment?
Yes. Dr. Uchenna Nebeolisa accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.